无创产前检测发现性染色体非整倍体的临床经验:准确性与患者决策
该回顾性队列研究分析了2013年1月至2017年9月间136例NIPT性染色体非整倍体阳性结果,其中45,X占73例(53.7%),性染色体三体62例(45.6%),性染色体四体1例。134例可存活妊娠中仅46例(34.3%)选择产前诊断,超声异常者行侵入性检测比例更低(4/23;17.4% vs 24/46,52.2%)。64例中30例(46.9%)确诊核型一致。作者建议全面检测前后咨询并制定产后检测指南。
要点
- NIPT阳性性染色体非整倍体中45,X占53.7%,性染色体三体占45.6%。
- 仅34.3%孕妇选择产前诊断,超声异常者侵入性检测比例更低(17.4% vs 52.2%)。
- 确诊核型一致率46.9%,即使超声异常也非100%一致。
核心结论
- 本队列中多数患者(88/134;65.7%)拒绝产前诊断,即使存在相关超声发现。
- 作者推荐全面的检测前后咨询,应强调确诊检测的重要性和早期诊断的益处。
- 需要实践指南来明确提供者关于产后检测的责任。
研究设计与样本
- 回顾性队列研究,回顾2013年1月至2017年9月NIPT性染色体非整倍体阳性结果。
- 共136例NIPT阳性结果,其中134例为可存活妊娠。
主要发现
- 136例阳性中45,X 73例(53.7%),性染色体三体62例(45.6%),性染色体四体1例。
- 134例可存活妊娠中46例(34.3%)选择产前诊断。
- 超声异常者行侵入性检测4/23(17.4%),无超声发现者24/46(52.2%)。
- 64例中30例(46.9%)确诊核型与NIPT结果一致。
临床怎么用
- 作者推荐全面的检测前后咨询,应强调确诊检测的重要性和早期诊断的益处。
- 作者指出需要实践指南来明确提供者关于产后检测的责任。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objectives of the study are to assess the accuracy of noninvasive prenatal testing (NIPT) for sex chromosome aneuploidies (SCAs) and to investigate patient decision-making in clinical practice. STUDY DESIGN: This is a retrospective cohort study review of positive NIPT results for SCAs from January 2013 to September 2017. RESULTS: Of the 136 positive NIPT results for SCAs, 73 (53.7%) were positive for 45,X, 62 (45.6%) were a sex chromosome trisomy, and 1 was a sex chromosome tetrasomy. Of the 134 viable pregnancies, 46 (34.3%) elected to pursue prenatal diagnosis. Fewer women underwent invasive prenatal testing when counseled regarding a positive NIPT for monosomy X in the presence of suggestive ultrasound findings (4/23; 17.4%) compared with those who had a positive NIPT result without ultrasound findings (24/46, 52.2%). Abnormal karyotypes consistent with the NIPT result were confirmed in 30/64 (46.9%). Even in the context of ultrasound abnormalities, there was not 100% concordance. CONCLUSIONS: The majority (88/134; 65.7%) of patients in our cohort declined prenatal diagnosis even in the presence of associated ultrasound findings. Comprehensive pretest and posttest counseling is recommended and should address the importance of confirmatory testing and benefits of early diagnosis. Practice guidelines are needed to address provider responsibilities about postnatal testing.
引用
- Ramdaney A, Hoskovec J, Harkenrider J, et al. Clinical experience with sex chromosome aneuploidies detected by noninvasive prenatal testing (NIPT): Accuracy and patient decision-making. Prenat Diagn. 2018. PMID: 30068017. doi:10.1002/pd.5339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。